
United States · Information technology & services startup
Reify Health is a Boston-based company that provides cloud-based software solutions for the clinical trial ecosystem.
Funding reportedLast round: Series D
Reify Health is a Boston-based company that provides cloud-based software solutions for the clinical trial ecosystem.
Their technology accelerates the development of new therapies by connecting various stakeholders in the life science industry, including clinical research sites, biotechs, and large biopharmaceutical companies. The company's flagship product, StudyTeam, is designed to optimize clinical research operations. It features tools for efficient patient enrollment and a Referral Partner Interface that streamlines the recruitment process by allowing partners to directly import patient candidates into the system. StudyTeam is trusted by major industry players, including Amgen, which has adopted the platform across its global research portfolio. Reify Health's solutions are essential for enhancing connectivity among sponsors, sites, and patients in the clinical trial process.
Funding, as reported
From the SEC filings it signed: 2 on the team.
On the board, as filediDavid J. FleshmanMark J. FernandesNeeraj J. Agrawal
What they build
Known for
health carehealthcare provider engagementinformation technology & servicesunderserved community accessstudy coordination softwarepatient recruitment toolshospital & health careclinical trial managementtrial logistics managementworkflow automationhealthbiotechnologysaasservicesresearch and development in the physicalengineering
Built with from their website
Amazon SESGoogle Tag ManagerAmazon CloudFrontCanvaAtlassianPWATwitter AnalyticsMailChimpGoogle WorkspaceViewport Meta
Cisco Webex Control HubAmazon Simple Email ServiceHubspotAtlassian ConfluenceZoomInfo SalesWebflow HostingApple Business ManagerAI
Add your raise, your deck and your story, and put Reify Health in front of investors. Or tell us what we have wrong.